Why is Remdesivir still on hospital protocols and formularies when even the WHO recommends against it?

Dr. Paul Marik responds to the question of why Remdesivir is still on hospital protocols even though the WHO now recommends against it. Dr. Marik notes that it is driven by money and greed, and explains that data shows that Remdesivir is toxic, harms the kidneys and liver and increases a patient's risk of renal failure by 20 fold.

Formed by leading critical care specialists in March 2020, the Front Line COVID-19 Critical Care Alliance (FLCCC) has developed highly effective treatment protocols that aim to prevent and treat COVID-19 at all stages of the disease. We are a 100% donor-supported 501(c)(3) non-profit organization — our work would not be possible without you. Your gifts help us expand our reach and share the latest research available, for the health and well-being of all.

To donate online, click here:
https://covid19criticalcare.com/network-support/support-our-work/

To follow FLCCC, click here:
https://covid19criticalcare.com/follow-flccc-2/

To learn more about our protocols, click here:
https://covid19criticalcare.com/covid-19-protocols/

To register for weekly webinars, click here:
https://geni.us/FLCCC_Webinar_Register

To buy FLCCC gear, click here:
https://supportflccc.store/
Content Managed by ContentSafe.co